Triangle Biotechnology, Inc.
PrivateLast Round
Debt
Aug 2, 2022
Total Funding Raised
$2.57M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Triangle Biotechnology, Inc. is a biotechnology company that develops acoustic processing technologies and sonication reagents to improve the efficiency of biological sample preparation for next-generation sequencing and epigenetic assays.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Triangle Biotechnology, Inc. Comparables
Compare Triangle Biotechnology, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hologic, Inc. | 76% | |
| PerkinElmer | 74% | |
| Active Motif | 71% |
Triangle Biotechnology, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Aug 2, 2022 | ||||
| Grant | Feb 2, 2021 | ||||
| Grant | Sep 8, 2020 | ||||
| Grant | Apr 9, 2019 | ||||
| Accelerator | Jan 1, 2018 |
Triangle Biotechnology, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KickStart Venture Services | Accelerator |
| North Carolina Biotechnology Center | Debt |
| One North Carolina Small Business Program | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 4280% MoM, from 40 to 1.8K.
- Jun 19, 2026
Monthly visitors increased 333% from 49 to 212.
Triangle Biotechnology, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Triangle Biotechnology, Inc.'s valuation, stock price, and market status.
Is Triangle Biotechnology, Inc. a public or private company?
Triangle Biotechnology, Inc. is a private company.
What is the current stock price of Triangle Biotechnology, Inc.?
Triangle Biotechnology, Inc. is a private company, so its shares have no public market price. Caplight tracks Triangle Biotechnology, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Triangle Biotechnology, Inc. worth (valuation)?
Valuation information for Triangle Biotechnology, Inc. is not publicly available.
Can I buy Triangle Biotechnology, Inc. stock?
Triangle Biotechnology, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Triangle Biotechnology, Inc.'s last funding round?
Triangle Biotechnology, Inc.'s most recent funding round was Debt on August 2, 2022.
Who are the main investors in Triangle Biotechnology, Inc.?
Key investors in Triangle Biotechnology, Inc. include KickStart Venture Services, North Carolina Biotechnology Center, One North Carolina Small Business Program, National Institutes of Health (NIH).
Will Triangle Biotechnology, Inc. IPO soon?
No public IPO plans have been announced for Triangle Biotechnology, Inc..
How can I track Triangle Biotechnology, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Triangle Biotechnology, Inc.'s shares on secondary markets.